All Articles

A 22% AFFO surge and record RevPAR aren't luck. Inside Chatham Lodging's Q2 success driven by strategic buys and relentless operational efficiency.

In a 30-day blitz, India's Kerala state is overhauling its bureaucracy with AI and data-driven platforms, aiming to boost efficiency and attract investment.

As ADI Global Distribution begins trading independently, we dive into the numbers behind the Resideo spin-off. What does it mean for investors and the industry?

As Organigram preps its Q3 results, all eyes are on its German expansion and its ability to defend its top spot in the competitive Canadian market.

Private equity firm Ridgemont's buyout of ENTACT signals a major investment in the booming environmental services sector, fueled by regulation and ESG.

A strategic acquisition, backed by Monroe Capital, is set to expand vital pediatric therapy training, revealing how private credit fuels innovation in niche healthcare.

A little-known lung disease is on the rise, with diagnoses delayed for years. We explore why NTM is a growing public health challenge and how awareness is key.

Strong Q2 results, pivotal deals with AstraZeneca and MSK, and a clear path to profitability signal SOPHiA GENETICS is converting its AI platform into market leadership.

Behind Cat Financial's record quarter lies a story of surging global demand, shrewd risk management, and the hidden engine driving the world's heavy machinery.

A strategic delegation of 15 AI startups signals a new era. Taipei is not just selling tech; it's building a deep innovation ecosystem with Japan.

A new strategic alliance aims to dismantle geographic barriers in oncology by decentralizing diagnostics, a move with profound implications for patient access.

The major trade event launches a Hosted Buyer Programme to connect global firms with China's Greater Bay Area, aiming to reshape international sourcing.

Tokyo's JIJ Inc. secures $5.2M not just from VCs, but from industrial titans like ANA and Fujitsu, validating its hybrid AI-quantum optimization platform.

IDEAYA Biosciences advances its breakthrough melanoma drug toward FDA review while its $1.24B cash runway fuels a deep pipeline targeting cancer's toughest codes.

A new report reveals 91% of cloud identities are non-human, exposing a critical intelligence gap that traditional security models can't see.

A telemedicine giant's latest acquisition isn't just about growth; it's a strategic play to rebuild America's crumbling maternal care infrastructure from the ground up.

VestGen's expanded deal with AI platform Zocks is more than a tech upgrade. It’s a strategic maneuver aimed at solving the industry's twin crises: growth and succession.

MGI Tech's strategic alliance with NCSTAR in Queensland is set to accelerate medical breakthroughs by providing a full suite of cutting-edge 'multi-omics' tools.

As Bangkok prepares for BCT Expo 2026, Thailand is making a high-stakes play to lead Southeast Asia's green transition. But turning ambitious targets into tangible assets is the real challenge.

The Layer-3 project's new governance model balances community power with a core team safety net. Is this the pragmatic future for complex infrastructure?